FIALA J.:
Prevention of diseases using modem information technologies - interactive web pages and their effect
|
485 |
POKORNÝ J. Jr., MAREČEK V., DIZON J., RŮŽIČKA J., ČERVENÝ R., Di CARA :
Emergency resuscitation in the front line
|
491 |
HEROLD I.:
Red blood cells transfusion in critically ill from the point of view of evidence based medicine: new limits, new risks?
|
494 |
SOVOVÁ E.:
What have the new recommendations for cardiovascular disease prevention in adults taught us
- is it necessary to recalculate a previously assessed risk?
|
507 |
MATOUŠKOVÁ J.1, NEUŽIL P.1, KMONÍČEK P.1, ASCHERMANN O.1, NIEDERLE P.1, PAVLÍČEK V.2:
Tandem Heart used for treatment ofthe most severe forms of heart failure - left ventricular support.
|
512 |
ZEMAN P.:
Chronic viral hepatitises and their health and sociál aspects ař generál practitioner.
|
517 |
MAŠEK M.,1 BOUČEK J.,2 CVACHOVEC K.,1 BETKA J.2:
Epiglotitis — The Experience with patients hospitalized in
RES FN Motol.
|
519 |
WIDIMSKY J.:
News in treatment modalities of hypertension
|
522 |
ŠÍDOVÁ M, NIEDERLE P.:
Non-setroidal anti-inflammatory drugs - use in treatment of cardiovascular disease an cardiovascular risks.
|
526 |
HLUŠÍ A.:
Oral anticoagulant therapy
|
531 |
